欢迎进入环球UG官网(UG环球),环球UG官方网站:www.ugbet.us开放环球UG网址访问、环球UG会员注册、环球UG代理申请、环球UG电脑客户端、环球UG手机版下载等业务。

首页社会正文

皇冠官网:KPJ Healthcare likely to post higher revenue

admin2022-12-3029

皇冠登1登2登3www.99cx.vip)实时更新发布最新最快最有效的登1登2登3代理网址,包括新2登1登2登3代理手机网址,新2登1登2登3代理备用网址,皇冠登1登2登3代理最新网址,新2登1登2登3代理足球网址,新2网址大全。

PETALING JAYA: CGS-CIMB Research expects KPJ Healthcare Bhd to post higher revenue and core earnings per share (EPS) on a year-on-year (y-o-y) and quarter-on-quarter (q-o-q) basis in its upcoming second quarter results for financial year 2022 (2Q22).

This is based on a recent discussion with KPJ, which noted its patient volumes and bed occupancy rate (BOR) rose q-o-q in 2Q22.

“This is partly due to the impact of the Omicron Covid-19 variant, while we think revenue intensity should have also improved q-o-q on gradual fee hikes,” said CGS-CIMB Research in its latest report.

KPJ’s BOR also recovered to pre-pandemic levels of 66% to 67% at the end of May, it added.

The healthcare group’s health tourism (HT) revenue rose a robust 21% y-o-y in 1H22, albeit off a low base in 1H21 due to international border closures.

CGS-CIMB Research noted KPJ expects HT to form about 10% of its total revenue in FY22 and is set to grow 10% to 15% y-o-y in FY23.

Meanwhile, KPJ also projected cost savings from the centralisation of certain functions, such as procurement, credit facilities and management that were undertaken in the financial year 2021 to be offset by cost pressures for external service providers due to higher minimum wages in the near term.

,

皇冠官网www.hg108.vip)是一个开放皇冠正网即时比分、皇冠官方的平台。皇冠官网(www.hg108.vip)提供最新皇冠登录,皇冠APP下载包含新皇冠体育代理、会员APP,提供皇冠官网代理开户、皇冠官网会员开户业务。

,

On the group’s earnings outlook, CGS-CIMB Research said: “We project FY22 core EPS to jump 95% y-o-y from the low base in FY21 before increasing a further 28.4% in FY23 and 10.3% y-o-y in FY24.”

It expects this to stem from rising patient volumes post-pandemic recovery, structurally higher private healthcare demand and growing health tourism contribution.

Other positive factors include improving revenue intensity, cost savings from the centralisation of certain functions, recovery in associate earnings and normalisation of effective tax rate in FY22.

In another development, KPJ’s plans to divest its loss-making Indonesia operations are progressing well and likely to be concluded by end-2022, said CGS-CIMB Research.

“However, the completion of the sale of Jeta Gardens (JT) may be delayed slightly to end-2023 from 3Q23 previously,” it added.

The research house noted KPJ for now intends to reinvest the cash proceeds from the sale of its Indonesian operations to ramp up capacity at Damansara Specialist Hospital 2, while it does not project material cash proceeds from the JT sale.

CGS-CIMB Research has upgraded the stock to an “add” call with a slightly higher target price of RM1.04.

It noted the re-rating catalysts for KPJ include full recovery from Covid-19, rising HT contribution and sale of its foreign operations.


转载说明:本文转载自Sunbet。

网友评论

1条评论
  • 2022-12-30 00:17:18

    Từng hạnh động, sắc thái đều không có quá nhiều thay đổi, liên tiếp lặp lại mà chẳng chút đột phá, hoàn toàn đúng với câu "trăm vai như 1".别结局,我还想一直看

热门标签